Cytotoxicity of nickel zinc ferrite nanoparticles on cancer cells of epithelial origin

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2497-2508

  Al Qubaisi, Mothanna Sadiq ^a   Rasedee, Abdullah ^a   Flaifel, Moayad Husein ^b   Ahmad, Sahrim H J ^b   Hussein Al Ali, Samer ^a   Hussein, Mohd Zobir ^a   Eid, Eltayeb E M ^c   Zainal, Zulkarnain ^a   Saeed, Mohd ^a   Ilowefah, Muna ^a   Fakurazi, Sharida ^a   Mohd Isa, Norhaszalina ^a   El Zowalaty, Mohamed Ezzat ^a,d  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^c QASSIM UNIVERSITY   (Saudi Arabia)

^d ZAGAZIG UNIVERSITY   (Egypt)

Author keywords

Anticancer; Apoptosis; Cancer cells lines; NiZn ferrite nanoparticles

Indexed keywords

CASPASE 3; CASPASE 9; DOXORUBICIN; FERRITE; NANOPARTICLE; NICKEL ZINC FERRITE; OXALIPLATIN; TAMOXIFEN; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL DEATH; CELL STRUCTURE; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DRUG ANALYSIS; DRUG STRUCTURE; ENZYME ACTIVITY; EPITHELIUM; HUMAN; HUMAN CELL; LIVER CANCER; MICROSCOPY; ROENTGEN SPECTROSCOPY; SCANNING ELECTRON MICROSCOPY;

ANTICANCER; APOPTOSIS; CANCER CELLS LINES; NIZN FERRITE NANOPARTICLES;

ANTINEOPLASTIC AGENTS; CASPASE 3; CASPASE 9; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; DNA FRAGMENTATION; DRUG CARRIERS; FERRIC COMPOUNDS; HUMANS; METAL NANOPARTICLES; NICKEL; PARTICLE SIZE; SPECTROPHOTOMETRY, INFRARED; STATISTICS, NONPARAMETRIC; X-RAY DIFFRACTION; ZINC COMPOUNDS;

EID: 84880304249     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S42367     Document Type: Article

References (31)

1. Sun C, Lee JSH, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev. 2008;60(11):1252-1265.
2. Gu H, Ho PL, Tsang KWT, Wang L, Xu B. Using biofunctional magnetic nanoparticles to capture vancomycin-resistant enterococci and other gram-positive bacteria at ultralow concentration. J Am Chem Soc. 2003;125(51):15702-15703.
3. Taylor EN, Webster TJ. The use of superparamagnetic nanoparticles for prosthetic biofilm prevention. Int J Nanomedicine. 2009;4:145-152.
4. Peyre J, Humblot V, Méthivier C, Berjeauc JM, Pradier CM. Co-grafting of amino-poly-ethylene-glycol and magainin I on a TiO2 surface: Tests of antifouling and antibacterial activities. J Phys Chem B. 2012;116(47):13839-13847.
5. Lee KJ, An JH, Shin JS, Kim DH. Synthesis and characterization of bicalutamide-loaded magnetic nanoparticles as anti-tumor drug carriers. J Nanosci Nanotechnol. 2012;12(2):1611-1615.
6. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 2003;63(23):8122-8125.
7. Brunke O, Odenbach S, Jurgons R, Alexiou C, Hilger I, Beckmann F. Determination of the magnetic particle distribution in tumour tissue by means of x-ray tomography. J Phys Condens Matter. 2006;18(38):S2903.
8. Pray L. Molecular Diagnostics: New Growth, New Markets. Waltham, MA: Cambridge Healthtech Advisors; 2005.
9. Leuschner C, Kumar CSSR, Hansel W, Soboyejo W, Zhou J, Hormes J. LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. Breast Cancer Res Treat. 2006;99(2): 163-176.
10. Zhao Q, Wang L, Cheng R, et al. Magnetic nanoparticle-based hyper-thermia for head and neck cancer in mouse models. Theranostics. 2012;2(1):113-121.
11. Thomas LA, Dekker L, Kallumadil M, et al. Carboxylic acid-stabilised iron oxide nanoparticles for use in magnetic hyperthermia. J Mater Chem. 2009;19(36):6529-6535.
12. Babincov M, Altanerov V, Altaner C, Bergemann C, Babinec P. In vitro analysis of cisplatin functionalized magnetic nanoparticles in combined cancer chemotherapy and electromagnetic hyperthermia. IEEE Trans Nanobiosci. 2008;7(1):15-19.
13. Maeng JH, Lee DH, Jung KH, et al. Multifunctional doxorubicin-loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials. 2010;31(18): 4995-5006.
14. Jia Y, Yuan M, Yuan H, et al. Co-encapsulation of magnetic Fe3O4 nano-particles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery. Int J Nanomedicine. 2012;63:1697-1708.
15. Martin J. British National Formulary: September 2010. London. BMJ Group and RPS Publishing; 2010.
16. de Freitas ERL, Soares PRO, de Paula Santos R, et al. In vitro biological activities of anionic-Fe2O3 nanoparticles on human melanoma cells. J Nanosci Nanotechnol. 2008;8(5):2385-2391.
17. Yang G, Li X, Zhao Z, Wang W. Preparation, characterization, in vivo and in vitro studies of arsenic trioxide Mg-Fe ferrite magnetic nanoparticles. Acta Pharmacol Sin. 2009;30(12):1688-1693.
18. Tomitaka A, Koshi T, Hatsugai S, Yamada T, Takemura Y. Magnetic char-acterization of surface-coated magnetic nanoparticles for biomedical application. J Magn Magn Mater. 2011;323(10):1398-1403.
19. Ahamed M, Akhtar MJ, Siddiqui MA, et al. Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells. Toxicology. 2011;283(2-3):101-108.
20. Modak S, Ammar M, Mazaleyrat F, Das S, Chakrabarti PK. XRD, HRTEM and magnetic properties of mixed spinel nanocrystalline Ni-Zn-Cu-ferrite. J Alloys Compd. 2009;473(1-2):15-19.
21. Flaifel MH, Ahmad SH, Abdullah MH, Al-Asbahi BA. NiZn Ferrite filled thermoplastic natural rubber nanocomposites: effect of low temperature on their magnetic behaviour. Cryogenics. 2012;52(10):523-529.
22. Malich G, Markovic B, Winder C. The sensitivity and specificity of the MTS tetrazolium assay for detecting the in vitro cytotoxicity of 20 chemicals using human cell lines. Toxicology. 1997;124(3):179-192.
23. Shokri F, Heidari M, Gharagozloo S, Ghazi-Khansari M. In vitro inhibitory effects of antioxidants on cytotoxicity of T-2 toxin. Toxicology. 2000;146(2):171-176.
24. Miller FJ, Schlosser PM, Janszen DB. Haber's rule: a special case in a family of curves relating concentration and duration of exposure to a fixed level of response for a given endpoint. Toxicology. 2000;149(1): 21-34.
25. Al-Qubaisi M, Rozita R, Yeap SK, Omar AR, Ali AM, Alitheen NB. Selective cytotoxicity of goniothalamin against hepato-blastoma HepG2 cells. Molecules. 2011;16(4):2944-2959.
26. Hathaway HJ, Butler KS, Adolphi NL, et al. Detection of breast cancer cells using targeted magnetic nanoparticles and ultra-sensitive magnetic field sensors. Breast Cancer Res. 2011;13(5):R108.
27. Rozman KK, Doull J. Dose and time as variables of toxicity. Toxicology. 2000;144(1):169-178.
28. Tennekes HA. The significance of the Druckrey-Küpfmüller equation for risk assessment - The toxicity of neonicotinoid insecticides to arthropods is reinforced by exposure time: Responding to a Letter to the Editor by Drs C Maus and R Nauen of Bayer CropScience AG. Toxicology. 2011;280(3):173.
29. Häfeli UO, Riffle JS, Harris-Shekhawat L, et al. Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharm. 2009;6(5):1417-1428.
30. Lartigue L, Wilhelm C, Servais J, et al. Nanomagnetic sensing of blood plasma protein interactions with iron oxide nanoparticles: impact on macrophage uptake. ACS Nano. 2012;6(3):2665-2678.
31. Mitamura S, Ikawa H, Mizuno N, Kaziro Y, Itoh H. Cytosolic nuclease activated by caspase-3 and inhibited by DFF-45. Biochem Biophys Res Comm. 1998;243(2):480-484